A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Generating CRISPR/Cas9 Mediated Monoallelic Deletions to Study Enhancer Function in Mouse Embryonic Stem Cells

12.6K views

⸱

DOI:

10.3791/53552

⸱

April 2nd, 2016

 , 

In This Article

Summary

Experimental validation of enhancer activity is best approached by loss-of-function analysis. Presented here is an efficient protocol that uses CRISPR/Cas9 mediated deletion to study allele-specific regulation of gene transcription in F1 ES cells which contain a hybrid genome (Mus musculus129 x Mus castaneus).

Abstract

Enhancers control cell identity by regulating tissue-specific gene expression in a position and orientation independent manner. These enhancers are often located distally from the regulated gene in intergenic regions or even within the body of another gene. The position independent nature of enhancer activity makes it difficult to match enhancers with the genes they regulate. Deletion of an enhancer region provides direct evidence for enhancer activity and is the gold standard to reveal an enhancer's role in endogenous gene transcription. Conventional homologous recombination based deletion methods have been surpassed by recent advances in genome editing technology which enable rapid and precisely located changes to the genomes of numerous model organisms. CRISPR/Cas9 mediated genome editing can be used to manipulate the genome in many cell types and organisms rapidly and cost effectively, due to the ease with which Cas9 can be targeted to the genome by a guide RNA from a bespoke expression plasmid. Homozygous deletion of essential gene regulatory elements might lead to lethality or alter cellular phenotype whereas monoallelic deletion of transcriptional enhancers allows for the study of cis-regulation of gene expression without this confounding issue. Presented here is a protocol for CRISPR/Cas9 mediated deletion in F1 mouse embryonic stem (ES) cells (Mus musculus129 x Mus castaneus). Monoallelic deletion, screening and expression analysis is facilitated by single nucleotide polymorphisms (SNP) between the two alleles which occur on average every 125 bp in these cells.

Introduction

Transcriptional regulatory elements are critical for spatio-temporal fine tuning of gene expression during development1 and modification of these elements can result in disease due to aberrant gene expression2. Many disease-associated regions identified by genome wide association studies are in non-coding regions and have features of transcriptional enhancers3-4. Identifying enhancers and matching them with the genes they regulate is complicated as they are often located several kilobases away from the genes they regulate and may be activated in a tissue-specific manner5-6. Enhancer predictions are commonly based on histone ....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Designing and Constructing the gRNA

  1. To delete transcriptional enhancer regions use two gRNAs, one 5' and one 3' of the region of interest. Use the mouse UCSC genome browser track generated by the Zhang laboratory to identify unique gRNA sequences (http://www.genome-engineering.org15). Next check these gRNAs and their adjacent PAM for SNPs and indels using online tools provided by the Sanger Institute (www.sanger.ac.uk/sanger/Mouse_SnpViewer/rel-1211)27-28. To target both alleles with equal efficiency, avoid gRNA/PAM sequences that contain a SNP or indel.
    1. While choosing the gRNA, check for the feasibility of desi....

Access restricted. Please log in or start a trial to view this content.

Results

The protocol described here uses F1 ES cells to study cis-regulation of gene expression in monoallelic enhancer deleted cells generated using CRISPR/Cas9 genome editing (Figure 1). The gRNA and allele-specific primer design for genotyping and gene expression are the key factors in this approach. Each allele-specific primer set must be validated by qPCR to confirm allele specificity. Allele-specific primers that amplify only their respective genomic DNA target are.......

Access restricted. Please log in or start a trial to view this content.

Discussion

CRISPR/Cas9 mediated genome editing technology provides a straightforward, fast and inexpensive method for genome modification. The method detailed here to generate and analyze monoallelic enhancer deletion for functional enhancer characterization takes advantage of SNPs in F1 mouse cells. The advantages of this type of approach are: 1) monoallelic enhancer deletions do not produce confounding effects that occur when a critical enhancer is deleted from both alleles, i.e., a great reduction in the protein levels .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have read JoVE's policies on conflict of interest and have no conflicts to disclose.

Acknowledgements

We would like to thank all the members of the Mitchell lab for helpful discussions. This work was supported by the Canadian Institutes of Health Research, the Canada Foundation for Innovation and the Ontario Ministry of Research and Innovation (operating and infrastructure grants held by JAM).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Phusion High-Fidelity DNA PolymeraseNEBM0530Shigh fidelity DNA polymerase used in gRNA assembly
Gibson Assembly Master MixNEBE2611L
gRNA_Cloning VectorAddgene41824A target sequence is cloned into this vector to create the gRNA plasmid
pCas9_GFPAddgene44719Codon-optimized SpCas9 and EGFP co-expression plasmid
AflIINEBR0520S
EcoRINEBR3101S
Neon Transfection System 100 µL KitLife TechnologiesMPK10096Microporator transfection technology
prepGEMZyGEMPT10500genomic DNA extraction reagent
Nucleo Spin Gel & PCR Clean-upMacherey-Nagel740609.5
High-Speed Plasmid Mini KitGeneaidPD300
Maxi Plasmid Kit Endotoxin Free GeneaidPME25
SYBR select mix for CFXLife Technologies4472942qPCR reagent
iScript cDNA synthesis kitBio-rad170-8891Reverse transcription reagent
0.25% Trypsin with EDTALife Technologies25200072
PBS without Ca/Mg2+SigmaD8537
0.5 M EDTABioshopEDT111.500
HBSSLife Technologies14175095
1 M HEPESLife Technologies13630080
BSA fraction V (7.5%)Life Technologies15260037
Max Efficiency DH5α competent cellsInvitrogen18258012
FBSES cell qualifiedFBS is subjected to a prior testing in mouse ES cells for pluripotency
DMSOSigmaD2650
GlutamaxInvitrogen35050
DMEMLife Technologies11960069
Pencillin/StreptomycinInvitrogen15140
Sodium pyruvateInvitrogen11360
Non-essential aminoacidInvitrogen11140
β-mercaptoethanolSigmaM7522
96-well plateSarstedt83.3924
Sealing tapeSarstedt95.1994
CoolCell LXBiocisionBCS-405alcohol-free cell freezing container
CHIR99021Biovision1748-5Inhibitor for F1 ES cell culture
PD0325901Invivogeninh-pd32Inhibitor for F1 ES cell culture
LIFChemiconESG1107Inhibitor for F1 ES cell culture

References

  1. Sagai, T., Hosoya, M., Mizushina, Y., Tamura, M., Shiroishi, T. Elimination of a long-range cis-regulatory module causes complete loss of limb-specific Shh expression and truncation of the mouse limb. Development. 132 (4), 797-803 (2005).
  2. Kleinjan, D. A., Lettice, L. A.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

CRISPR/Cas9 Mediated DeletionMonoallelic DeletionAllele-Specific PrimersSingle Nucleotide PolymorphismsGuide RNA DesignElectroporation TransfectionFlow Cytometry SortingGenomic DNA ExtractionqPCR Deletion Screening